Want to see SG:1B1 full AI Analyst Report?
Top Page
HC Surgical Specialists Ltd
(SGX:1B1)
Select Model
Select Model
Rating:77Outperform
Price Target:
S$0.39
▲(7.22% Upside)
Action:Reiterated
Date:08/03/26
The score is driven primarily by strong financial performance (high profitability, robust and consistent cash generation, and a de-risked balance sheet) and very attractive valuation (low P/E and high dividend yield). These positives are partially offset by weak technicals, with the share price trading below all key moving averages.
Positive Factors
High Profitability
Sustained gross margins in the mid-80s and a ~44% net margin imply durable pricing power and a capital-light, high-margin business model. This supports stable internal funding for R&D/dividends and preserves resilience across industry cycles over the next several months.
Negative Factors
Revenue and Earnings Volatility
Irregular top-line and profit swings reduce forecasting reliability and make capital allocation harder. For a small specialist, recurring volatility can threaten consistent investment, hiring, or dividend plans and raises execution risk over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability
Sustained gross margins in the mid-80s and a ~44% net margin imply durable pricing power and a capital-light, high-margin business model. This supports stable internal funding for R&D/dividends and preserves resilience across industry cycles over the next several months.
Read all positive factors
HC Surgical Specialists Ltd (1B1) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$50.76M
Dividend Yield6.12%
Average Volume (3M)50.29K
Price to Earnings (P/E)5.8
Beta (1Y)0.20
Revenue Growth1.42%
EPS Growth-17.12%
CountrySG
Employees18
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)0.07
Shares Outstanding156,309,900
10 Day Avg. Volume16,820
30 Day Avg. Volume50,290
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)2.79
Price to Sales (P/S)3.01
P/FCF Ratio7.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HC Surgical Specialists Ltd Business Overview & Revenue Model
Company Description
HC Surgical Specialists Limited, an investment holding company, primarily delivers a diverse spectrum of medical services across Singapore. Through its network of clinics, the company specializes in endoscopic procedures, such as gastroscopies and...
How the Company Makes Money
null...
HC Surgical Specialists Ltd Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
82
Very Positive
Cash Flow
88
Very Positive
| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.14M | 19.38M | 19.11M | 18.81M | 19.08M | 19.31M |
| Gross Profit | 8.47M | 6.29M | 16.11M | 15.96M | 16.45M | 16.67M |
| EBITDA | 5.35M | 6.59M | 10.88M | 7.01M | 5.96M | 9.59M |
| Net Income | 9.03M | 6.98M | 8.44M | 3.85M | 2.92M | 6.38M |
Balance Sheet | ||||||
| Total Assets | 28.93M | 32.56M | 27.27M | 27.84M | 31.26M | 30.96M |
| Cash, Cash Equivalents and Short-Term Investments | 6.96M | 8.08M | 5.73M | 8.06M | 10.26M | 6.93M |
| Total Debt | 2.40M | 2.69M | 2.78M | 4.34M | 5.50M | 6.25M |
| Total Liabilities | 6.14M | 11.98M | 6.52M | 13.37M | 19.18M | 19.74M |
| Stockholders Equity | 23.11M | 20.91M | 20.95M | 14.69M | 12.10M | 11.00M |
Cash Flow | ||||||
| Free Cash Flow | 6.95M | 7.71M | 6.75M | 6.23M | 6.51M | 6.83M |
| Operating Cash Flow | 7.42M | 7.80M | 7.23M | 6.30M | 7.22M | 7.05M |
| Investing Cash Flow | 3.50M | 158.00K | -444.00K | 2.84M | -1.72M | -1.99M |
| Financing Cash Flow | -9.17M | -5.28M | -9.05M | -7.97M | -6.24M | -9.12M |
HC Surgical Specialists Ltd Technical Analysis
Negative
0.36
Price Trends
0.37
Negative
0.37
Negative
0.36
Negative
Market Momentum
-0.01
Positive
32.00
Neutral
13.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:1B1, the sentiment is Negative. The current price of 0.36 is above the 20-day moving average (MA) of 0.36, below the 50-day MA of 0.37, and below the 200-day MA of 0.36, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 32.00 is Neutral, neither overbought nor oversold. The STOCH value of 13.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:1B1.
HC Surgical Specialists Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | S$50.76M | 5.78 | 40.98% | 3.37% | 1.42% | -17.12% | |
70 Outperform | S$30.95M | 9.91 | 17.85% | 7.30% | -3.11% | -21.50% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | S$48.03M | -11.48 | -2.36% | ― | 5.73% | -100.00% |
* Healthcare Sector Average
SG:1B1
HC Surgical Specialists Ltd
0.34
0.03
9.68%
SG:1J5
Hyphens Pharma International Ltd.
0.37
0.08
29.43%
SG:546
Medtecs International Corporation Ltd.
0.11
-0.01
-9.60%
SG:8K7
UG Healthcare Corp. Ltd.
0.07
-0.03
-33.33%
SG:MIJ
Alliance Healthcare Group Ltd.
0.16
0.03
23.08%
SG:OTX
Medinex Ltd.
0.23
0.02
7.14%
HC Surgical Specialists Ltd Corporate Events
HC Surgical Specialists Delivers Steady Revenue, Lower FY2026 Profit but Maintains Dividend and Expands Specialist Network
Jul 30, 2026
HC Surgical Specialists Limited reported FY2026 revenue of S$19.38 million, up 1.4% year-on-year, while profit attributable to shareholders fell 17.2% to S$6.98 million, largely due to non-operational fair value losses on derivative financial inst...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.